FDA clears Sectras full-field digital mammo system

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
Screening mammography with breast tomosynthesis in a 57-year-old woman. Image source: RadioGraphics
The FDA has granted approval for the 510(k) application by Sectra Medical Systems to sell the Sectra MicroDose L30 full-field digital mammography (FFDM) unit in the U.S.

The Linköping, Sweden-based company said its Sectra MicroDose Mammography L30 is a flat-panel FFDM system with scanning multislit geometry and a 24 x 26-cm field-of-view, as well as photon-counting technology.

Until accreditation is available from their accreditation bodies, mammography facilities that want to use this unit under their existing Mammography Quality Standards Act (MQSA) certificate must apply to the FDA’s Certification Extension Program.

 

Justine Varieur Cadet

Related Content

MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.